Skip to content

Food and Drug Recall.org

The Latest Food & Drug Recall and Safety News

FDA approves product to prevent bleeding in people with rare genetic defect

February 18, 2011Drug Recalls & Safety Notices, Drug Safety Information Podcasts, Food & Drug Recalls, Food Safety Newsadmin

The U.S. Food and Drug Administration today approved Corifact, the first product intended to prevent bleeding in people with the rare genetic defect congenital Factor XIII deficiency.

Post navigation

← FDA warns against certain uses of asthma drug terbutaline for preterm labor PHOTO – Hua Shing International Trading Corp Issues an Alert on Uneviscerated Fish →
Proudly powered by WordPress